Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.

MLA

Visser, Loes E., et al. “Allelic Variants of Cytochrome P450 2C9 Modify the Interaction between Nonsteroidal Anti-Inflammatory Drugs and Coumarin Anticoagulants.” Clinical Pharmacology and Therapeutics, vol. 77, no. 6, June 2005, pp. 479–85. EBSCOhost, https://doi.org/10.1016/j.clpt.2005.02.009.

APA

Visser, L. E., van Schaik, R. H. N., van Vliet, M., Trienekens, P. H., De Smet, P. A. G. M., Vulto, A. G., Hofman, A., van Duijn, C. M., & Stricker, B. H. C. (2005). Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. Clinical Pharmacology and Therapeutics, 77(6), 479–485. https://doi.org/10.1016/j.clpt.2005.02.009

Chicago

Visser, Loes E, Ron H N van Schaik, Martin van Vliet, Paul H Trienekens, Peter A G M De Smet, Arnold G Vulto, Albert Hofman, Cornelia M van Duijn, and Bruno H Ch Stricker. 2005. “Allelic Variants of Cytochrome P450 2C9 Modify the Interaction between Nonsteroidal Anti-Inflammatory Drugs and Coumarin Anticoagulants.” Clinical Pharmacology and Therapeutics 77 (6): 479–85. doi:10.1016/j.clpt.2005.02.009.